Belluscura Expands Its Oxygen Enrichment Patent Portfolio

Belluscura Expands Its Oxygen Enrichment Patent Portfolio

LONDON, U.K. AND PLANO, TX, U.S. (19 May 2022) –  Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that three additional US patents have recently issued, increasing the...